Leukemia, acute lymphocytic, susceptibility to, 1
MONDO:0013108Also known as: T-cell acute lymphoblastic leukemia, somatic, leukemia, T-cell acute lymphoblastic, somatic, leukemia, T-cell acute lymphocytic, somatic, leukemia, acute lymphoblastic, somatic, leukemia, acute lymphocytic, Philadelphia chromosome positive, somatic, leukemia, acute lymphocytic, susceptibility to, 1, ALL, All1
76 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
New hope for tough leukemias? trial of vodobatinib begins, then stops
Disease control TerminatedThis study tested a new drug called Vodobatinib (K0706) in people with chronic myeloid leukemia or a related leukemia who had not responded to at least three other treatments. The trial was split into parts: first in healthy volunteers to check safety, then in patients to find th…
Phase: PHASE1, PHASE2 • Sponsor: Sun Pharma Advanced Research Company Limited • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New drug combo for kids with resistant leukemia shows early promise but study halted
Disease control TerminatedThis study tested a targeted cancer drug called ponatinib combined with standard chemotherapy in children and young adults up to age 21 with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) that had come back or stopped responding to other treatments. The g…
Phase: PHASE1, PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC